Candriam SCA’s NxStage Medical Inc. NXTM Stock Holding History

Candriam SCA’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-92,842	Closed	-$2.66M	–	854
2018 Q4	$2.66M	Hold	92,842	–	–	0.04%	403
2018 Q3	$2.59M	Buy	+92,842	New	+$2.61M	0.03%	440
2015 Q2	–	Sell	-50,000	Closed	-$865K	–	677
2015 Q1	$865K	Buy	+50,000	New	+$883K	0.02%	468

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Candriam SCA's NXTM Position: Q1 2019 in Review

Candriam SCA sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 92,842 shares — an estimated $2.66M sold.

Candriam SCA first reported a position in NXTM in Q1 2015 and held it in 3 quarters. The position peaked at $2.66M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Candriam SCA reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Candriam SCA sold 92,842 NxStage Medical Inc. shares in Q1 2019, an estimated $2.66M.
Candriam SCA first reported a position in NxStage Medical Inc. in Q1 2015 and held it in 3 quarters.
Candriam SCA's NxStage Medical Inc. position peaked at $2.66M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.